Clin2
NCT07219082Worth exploringRecruiting

Fentanyl safety education for people who use stimulants

Drug OverdoseDrug Overdose Accidental

Part of Mental health clinical trials.

This study is testing a program called BSAFE that teaches people who use stimulants like cocaine or methamphetamine how to stay safer around fentanyl. It aims to prevent accidental fentanyl exposure and its harms.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
160 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years old or older
  • You use cocaine or methamphetamine on most days (at least 7 out of the last 30 days)
  • A drug test shows you have used cocaine or methamphetamine recently, but you have not used opioids
  • You have had a recent accidental exposure to fentanyl, such as feeling very sleepy or having a positive drug test you didn't expect
  • You can name at least two people who can usually tell us how to reach you

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06327061Recruiting
Opioid overdose prevention with friends and family

This trial tests a program where people who use opioids learn to educate their friends and family about overdose prevention. It may help build a safer support network in Baltimore.

Baltimore, Maryland
NCT06633900Recruiting· Phase 2/Phase 3
Testing naltrexone to prevent overdose in stimulant users

This trial tests whether naltrexone, a medication that blocks the effects of opioids, can help prevent overdose in people who use stimulants like cocaine or methamphetamine. It may be a good fit if you are at risk for HIV or living with HIV, and have a stimulant use disorder or use stimulants at least 10 days per month.

San Francisco, California
NCT07469501Not yet recruiting· Phase 4
Comparing low-dose vs. direct-inject buprenorphine for fentanyl users

This study compares two ways to start buprenorphine (a medicine for opioid use disorder) for people who use fentanyl daily. One group gets a low starting dose, the other gets a direct injection. The goal is to see which approach helps people stay in treatment longer.

San Francisco, California
NCT07348172Not yet recruiting· Early Phase 1
Study on drug liking of fentanyl during procedures

This study measures how much people enjoy the feeling of the pain medicine fentanyl when it's given during a routine medical procedure. The goal is to understand if a different drug can reduce the pleasant effects of opioids, which may help lower the risk of addiction.

Palo Alto, California
NCT06699953Enrolling by invitation
EEG study of fentanyl and how it relates to drug liking

This study looks at how fentanyl affects brain waves (EEG) and whether those brain changes are linked to how much a person likes the drug. If you are having surgery with fentanyl, you may be able to join.

Palo Alto, California
NCT07459166Recruiting· Phase 2
Testing a new drug for fentanyl overdose

This study tests a new drug, CS-1103, to see if it can safely help reverse the effects of fentanyl (a strong opioid) even after a naloxone block. Healthy volunteers who have used opioids before will be given fentanyl and then the study drug, while researchers monitor safety and how the drug works.

Glendale, California

Hear when a new Drug Overdose trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.